International Journal of
Reproductive Biomedicine
Thu, Apr 25, 2024
[Archive]
Volume 13, Issue 8 (9-2015)
IJRM 2015, 13(8): 489-494 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Farhadi M, Mohseni Kouchesfahani H, Shockravi A, Foroozanfar M, Parivar K. The adverse effects of the methoxsalen and ultraviolent A radiation on spermatogenesis in mice. IJRM 2015; 13 (8) :489-494
URL: http://ijrm.ir/article-1-674-en.html
URL: http://ijrm.ir/article-1-674-en.html
Mona Farhadi * 
1, Homa Mohseni Kouchesfahani2 , Abass Shockravi3 , Mosaeeb Foroozanfar2 , Kazem Parivar2
1, Homa Mohseni Kouchesfahani2 , Abass Shockravi3 , Mosaeeb Foroozanfar2 , Kazem Parivar2
1- Department of Mcrobiology, Karaj Branch, Islamic Azad University, Karaj, Iran , monafarhadi@yahoo.com
2- Department of Biology, Kharazmi University, Tehran, Iran
3- Faculty of Chemistry, Kharazmi University, Tehran, Iran
2- Department of Biology, Kharazmi University, Tehran, Iran
3- Faculty of Chemistry, Kharazmi University, Tehran, Iran
Abstract: (2475 Views)
Background: Different investigation showed that 5-methoxypsoralen and 8- methoxypsoralen reduce birth rates in the rats.
Objective: In this study we worked out the effect of methoxsalen together with ultraviolent A (UVA) radiation on mature Balb/C mice spermatogenesis.
Materials and Methods: The LD50 standard was determined 160 mg/kg and the UVA dose which causes erythema was calculated 0.046 J/cm2. A sub-lethal dose of 80 mg/kg of methoxsalen solution was injected intrapritoneally to mature mice and after one hour they were exposed to UVA radiation for 20 minutes. Experiments applied included methoxsalen alone, methoxsalen with UVA, UVA alone, sham group (a group received Tween 80), and control group (N=6). In all experimental groups except UVA alone group, injections were carried out, during two consecutive weeks. Serial cross sections (5 µm thickness) were prepared for morphological and histological studies. Tunica albuginea diameter, and number of type A and type B spermatogonia and histological investigation of the testes were measured.
Results: Microscopical and statistical analyses showed significant anomalies among the experimental groups compared to control and sham group. These anomalies included decrease the body weight; increase the relative testis weight; and decrease the number of spermapogonia (type A and B), primary spermatocytes, spermatids and sperms in experimental groups I and II compared to control group. Our results showed the number of spermatozoa in experimental group I was 22.6±2.12, in experimental group II was 33.6±2.05 and in control group was 44.3±2.77 (p<0.05). Moreover in some experimental groups (I and II) shrinkage of seminiferous tubules and release of primary spermatocyte and spermatids were observed to the lumen of them.
Conclusion: It is concluded from the results of this work that treatment with methoxsalen with UVA can damage and disorganize seminiferous tubules and decrease spermatogenic cells.
Objective: In this study we worked out the effect of methoxsalen together with ultraviolent A (UVA) radiation on mature Balb/C mice spermatogenesis.
Materials and Methods: The LD50 standard was determined 160 mg/kg and the UVA dose which causes erythema was calculated 0.046 J/cm2. A sub-lethal dose of 80 mg/kg of methoxsalen solution was injected intrapritoneally to mature mice and after one hour they were exposed to UVA radiation for 20 minutes. Experiments applied included methoxsalen alone, methoxsalen with UVA, UVA alone, sham group (a group received Tween 80), and control group (N=6). In all experimental groups except UVA alone group, injections were carried out, during two consecutive weeks. Serial cross sections (5 µm thickness) were prepared for morphological and histological studies. Tunica albuginea diameter, and number of type A and type B spermatogonia and histological investigation of the testes were measured.
Results: Microscopical and statistical analyses showed significant anomalies among the experimental groups compared to control and sham group. These anomalies included decrease the body weight; increase the relative testis weight; and decrease the number of spermapogonia (type A and B), primary spermatocytes, spermatids and sperms in experimental groups I and II compared to control group. Our results showed the number of spermatozoa in experimental group I was 22.6±2.12, in experimental group II was 33.6±2.05 and in control group was 44.3±2.77 (p<0.05). Moreover in some experimental groups (I and II) shrinkage of seminiferous tubules and release of primary spermatocyte and spermatids were observed to the lumen of them.
Conclusion: It is concluded from the results of this work that treatment with methoxsalen with UVA can damage and disorganize seminiferous tubules and decrease spermatogenic cells.
Type of Study: Original Article |
References
1. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). J Engl Med 1997; 336: 1041-1045. [DOI:10.1056/NEJM199704103361501]
2. McDermott DC, Hoyer PB, Diawara MM. Morphological evidence of 8-MOP-induced apoptosis in rat ovary. J Toxin Reviews 2003; 22: 701-708. [DOI:10.1081/TXR-120026923]
3. Kaur P, Arora R, Gill N. Review on oxygen heterocycles. Indo American J of Pharmaceutical Research 2013; 3: 9067-9084.
4. Shockravi A, Valizadeh H, Heravi MM. A one-pot and convenient synthesis of coumarins in solventless system. Phosphorus Sulfur and Silicon 2003; 178: 501-504. [DOI:10.1080/10426500307915]
5. Brickl R, Schmid J, Koss F. Clinical pharmacology of oral psoralen drugs. Photo-dermatol 1984; 1: 174-186.
6. Zarebska Z, Waszkowska E, Caffieri S, Dall'Acqua F. PUVA (psoralen+ UVA) photochemotherapy: processes triggered in the cells. Il Farmaco 2000; 55: 515-520. [DOI:10.1016/S0014-827X(00)00076-8]
7. Roelandts R. Mutagenicity and carcinogenicity of methoxsalen plus UV-A. Arch dermatol 1984; 120: 662-669. [DOI:10.1001/archderm.1984.01650410104025]
8. Laufersweiler MC, Gadagbui B, Baskerville-Abraham IM, Maier A, Willis A, Scialli AR, et al. Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern. Regul Toxicol Pharmacol 2012; 62: 160-182. [DOI:10.1016/j.yrtph.2011.09.004]
9. Diawaraa MM, Chavez KJ, Simpleman D, Williams DE, Franklin MR, Hoyer PB. The psoralens adversely affect reproductive function in male wistar rats. Reprod Toxicol 2001; 15: 137-144. [DOI:10.1016/S0890-6238(01)00118-6]
10. Fattahi E, Jorsaraei SGA, Gardaneh M, Marzony ET. The Effect of 8-Methoxypsoralen on Pituitary-Gonad Axis and Ovarian Function in Mice. Cell J 2013; 15: 206.
11. Bazrafkan M, Sobhani A. Study of Spermatogenesis in Wistar Adult Rats Administrated to Long Term of Ruta Graveolens. Jentashapir J Health Research 2014; 5: e21870. [DOI:10.17795/jjhr-21870]
12. Sailani M, Moeini H. Effect of Ruta graveolens and Cannabis sativa alcoholic extract on spermatogenesis in the adult wistar male rats. Indian J Urol 2007; 23: 257. [DOI:10.4103/0970-1591.33720]
13. Yang WM, Chang MS, Park SK. Effects of Psoralea corylifolia on the cAMP-responsive element modulator (CREM) expression and spermatogenesis in rats. J Ethnopharmacol 2008; 117: 503-506. [DOI:10.1016/j.jep.2008.02.016]
14. Khouri NA, El-Akawi Z. Antiandrogenic activity of Ruta graveolens L in male Albino rats with emphasis on sexual and aggressive behavior. Neuro Endocrinol Lett 2005; 26: 823-829.
15. Liu D, Fernandez BO, Hamilton A, Lang NN, Gallagher JM, Newby DE, et al. UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol 2014; 134: 1839-1846. [DOI:10.1038/jid.2014.27]
16. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011; 65: 137-174. [DOI:10.1016/j.jaad.2010.11.055]
17. Neuner P, Charvat B, Knobler R, Kirnbauer R, Schwarz A, Luger TA, et al. Cytokine release by peripheral blood mononuclear cells is affected by 8‐methoxypsoralen plus UV‐A. Photochem Photobiol 1994; 59: 182-188. [DOI:10.1111/j.1751-1097.1994.tb05020.x]
18. Stern RS, Bagheri S, Nichols K, Study PFU. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002; 47: 33-39. [DOI:10.1067/mjd.2002.124618]
19. Allanson M, Domanski D, Reeve VE. Photoimmunoprotection by UVA (320–400 nm) radiation is determined by UVA dose and is associated with cutaneous cyclic guanosine monophosphate. J Invest Dermatol 2006; 126: 191-197. [DOI:10.1038/sj.jid.5700050]
20. Schoonderwoerd S, van Henegouwen GB, Persons C, Caffieri S, Dall'Acqua F. Photobinding of 8-methoxypsoralen, 4, 6, 4′-trimethylangelicin and chlorpromazine to Wistar rat epidermal biomacromolecules in vivo. J Photochem Photobiol B: Biology 1991; 10: 257-268. [DOI:10.1016/1011-1344(91)85007-4]
21. Arabzadeh A, Bathaie S, Farsam H, Amanlou M, Saboury A, Shockravi A, et al. Studies on mechanism of 8-methoxypsoralen–DNA interaction in the dark. Inte J pharm 2002; 237: 47-55. [DOI:10.1016/S0378-5173(02)00020-0]
22. Farhadi M, Fattahi E, Kouchesfahani HM, Shockravi A, Parivar K. The Adverse Effects of Methoxsalen on the oogenesis of Balb/C Mice. Cell J 2014; 15: 348.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
